| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J A Verhelst, A L Froud, R Touzel, J A Wass, G M Besser, A B Grossma. Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study. Acta endocrinologica. vol 125. issue 4. 1992-01-02. PMID:1683503. |
acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study. |
1992-01-02 |
2023-08-11 |
Not clear |
| M H Samuels, P Henry, B Kleinschmidt-Demasters, K Lillehei, E C Ridgwa. Pulsatile prolactin secretion in hyperprolactinemia due to presumed pituitary stalk interruption. The Journal of clinical endocrinology and metabolism. vol 73. issue 6. 1992-01-02. PMID:1955511. |
alternatively, the mild hyperprolactinemia associated with large hypothalamic-pituitary tumors may represent partial impairment of dopamine secretion, with sufficient pituitary dopamine levels to maintain normal prl pulse frequency. |
1992-01-02 |
2023-08-11 |
human |
| H Hotta, H Ito, K Matsuda, A Sato, H Tohg. Age-related changes in rates of basal secretion of immunoreactive vasoactive intestinal polypeptide and dopamine into pituitary stalk blood from the hypothalamus in anesthetized male rats. The Japanese journal of physiology. vol 41. issue 2. 1991-12-02. PMID:1942666. |
these results indicate that the basal secretion of hypothalamic vip is well maintained, while that of hypothalamic dopamine is augmented in aged rats with hyperprolactinemia. |
1991-12-02 |
2023-08-11 |
rat |
| M I Balabolkin, G A Gerasimov, E E Gubernatorov, L A Kizym. [Role of enzymes of dopamine metabolism in the regulation of prolactin and thyrotropin secretion in hyperprolactinemia]. Problemy endokrinologii. vol 37. issue 3. 1991-12-02. PMID:1946287. |
[role of enzymes of dopamine metabolism in the regulation of prolactin and thyrotropin secretion in hyperprolactinemia]. |
1991-12-02 |
2023-08-11 |
Not clear |
| R Paradisi, G Grossi, A Pintore, S Venturoli, E Porcu, M Capelli, C Flamign. Evidence for a pathological reduction in brain dopamine metabolism in idiopathic hyperprolactinemia. Acta endocrinologica. vol 125. issue 3. 1991-12-02. PMID:1950338. |
evidence for a pathological reduction in brain dopamine metabolism in idiopathic hyperprolactinemia. |
1991-12-02 |
2023-08-11 |
human |
| R Paradisi, G Grossi, A Pintore, S Venturoli, E Porcu, M Capelli, C Flamign. Evidence for a pathological reduction in brain dopamine metabolism in idiopathic hyperprolactinemia. Acta endocrinologica. vol 125. issue 3. 1991-12-02. PMID:1950338. |
we measured urinary dopamine, norepinephrine, epinephrine, vanillylmandelic acid, homovanillic acid, 3,4-dihydroxyphenylacetic acid and total 3-methoxy-4-hydroxyphenylglycol levels in 12 women with idiopathic hyperprolactinemia before and during either peripheral dopa-decarboxylase blockade, by carbidopa, or dopamine beta-hydroxylase blockade, by disulfiram. |
1991-12-02 |
2023-08-11 |
human |
| R Paradisi, G Grossi, A Pintore, S Venturoli, E Porcu, M Capelli, C Flamign. Evidence for a pathological reduction in brain dopamine metabolism in idiopathic hyperprolactinemia. Acta endocrinologica. vol 125. issue 3. 1991-12-02. PMID:1950338. |
these data support the existence of a quantitatively reduced brain dopamine activity in idiopathic hyperprolactinemia. |
1991-12-02 |
2023-08-11 |
human |
| S A Tan, L G Ta. Hyperiodotyrosinemia-induced hyperprolactinemia and hyperaldosteronism. Hormone research. vol 34. issue 2. 1991-07-24. PMID:2129037. |
since iodotyrosines are tyrosine hydroxylase inhibitors, the hyperiodotyrosinemia causes dopamine synthesis inhibition, and induces the hyperprolactinemia and hyperaldosteronism. |
1991-07-24 |
2023-08-11 |
Not clear |
| T Tanaka, S Fujimot. Endocrinological environment of polycystic ovarian disease. Hormone research. vol 33 Suppl 2. 1991-07-09. PMID:2128882. |
although the cause of both inappropriate gonadotropin secretion and occurrence of mild hyperprolactinemia in pcod have not been fully elucidated, decrease in numbers of receptor for dopamine is thought to be one of the main causes of them from the present data obtained by metoclopramide injection administered during the continuous infusion of dopamine. |
1991-07-09 |
2023-08-11 |
Not clear |
| M I Balabolkin, G A Gerasimov, T R Gorokhova, A V Liubimo. [Hyperprolactinemia syndrome in men]. Sovetskaia meditsina. issue 4. 1990-08-30. PMID:2374967. |
therapy with dopamine agonists (lisenyl, parlodel) was found most effective in type i hyperprolactinemia syndrome, associated with essential prolactin hypersecretion and oligospermia. |
1990-08-30 |
2023-08-11 |
human |
| J A Kremer, P F van der Heijden, L A Schellekens, C M Thomas, J Brownell, R Rollan. Postpartum return of pituitary and ovarian activity during lactation inhibition with the new dopamine agonist CV 205-502 and during normal lactation. Acta endocrinologica. vol 122. issue 6. 1990-08-24. PMID:1973867. |
the new nonergot dopamine agonist cv 205-502 appears to be a promising alternative in the treatment of hyperprolactinemia. |
1990-08-24 |
2023-08-11 |
Not clear |
| N N Tkachenko, V V Potin, S V Beskrovnyĭ, L G Nosov. [The reaction of the hypophysis to thyroliberin and metoclopramide in women with hyperprolactinemia]. Problemy endokrinologii. vol 36. issue 2. 1990-08-08. PMID:2114023. |
the presence and a degree of hyperprolactinemia in patients with primary hypothyroidism depends, probably, on the ratio of a stimulating effect of endogenous thyroliberin and inhibitory action of dopamine on hypophyseal lactotrophs. |
1990-08-08 |
2023-08-11 |
Not clear |
| N G Weiland, P M Wis. Hyperprolactinemia decreases naloxone binding in the arcuate nucleus of ovariectomized rats. Neuroendocrinology. vol 50. issue 6. 1990-03-07. PMID:2559342. |
this theory provides an explanation for a mechanism for the suppression of endogenous prl and lh by hyperprolactinemia: a decrease in opiate receptors will decrease opiate suppression of dopamine neurons allowing dopamine activity to increase. |
1990-03-07 |
2023-08-11 |
rat |
| R M Perovich, J A Lieberman, W W Fleischhacker, J Alvi. The behavioral toxicity of bromocriptine in patients with psychiatric illness. Journal of clinical psychopharmacology. vol 9. issue 6. 1990-01-22. PMID:2574194. |
dopamine agonists may be useful in the treatment of neuroleptic-induced hyperprolactinemia and movement disorders; it is a treatment approach that has been avoided for fear of inducing or exacerbating psychotic symptoms. |
1990-01-22 |
2023-08-11 |
Not clear |
| N V Speranskaia, T V Ovsiannikova, A N Kerova, T Ia Pshenichnikov. [The causes of infertility in hyperprolactinemia]. Problemy endokrinologii. vol 35. issue 5. 1990-01-11. PMID:2511569. |
the authors arrived at a conclusion that stable hyperprolactinemia resulted from disorder of the receptor apparatus of lactotrophs with the resultant nonsusceptibility of the latter to an inhibitory effect of dopamine to prolactin secretion. |
1990-01-11 |
2023-08-11 |
Not clear |
| P C Doherty, S J Lane, K A Pfeil, W W Morgan, A Bartke, M S Smit. Extra-hypothalamic dopamine is not involved in the effects of hyperprolactinemia on male copulatory behavior. Physiology & behavior. vol 45. issue 6. 1989-12-11. PMID:2813534. |
extra-hypothalamic dopamine is not involved in the effects of hyperprolactinemia on male copulatory behavior. |
1989-12-11 |
2023-08-11 |
rat |
| Y Gonen, R F Caspe. Does transient hyperprolactinemia during ovarian hyperstimulation interfere with conception or pregnancy outcome? Fertility and sterility. vol 51. issue 6. 1989-07-13. PMID:2721718. |
these results do not support treatment of transient hyperprolactinemia with dopamine agonists in ivf patients. |
1989-07-13 |
2023-08-11 |
human |
| K A Gregerson, M Selmanof. Selective effects of hyperprolactinemia on in vitro dopamine release from median eminence synaptosomes. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 8. issue 7. 1989-06-29. PMID:3249238. |
selective effects of hyperprolactinemia on in vitro dopamine release from median eminence synaptosomes. |
1989-06-29 |
2023-08-11 |
rat |
| O Serri, H Beauregard, M Somma, R Comtois, N Jilwan, J Hard. Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia. Clinical and investigative medicine. Medecine clinique et experimentale. vol 11. issue 6. 1989-04-13. PMID:3229037. |
however, patients with idiopathic hyperprolactinemia were hyposensitive to dopamine (p less than 0.05). |
1989-04-13 |
2023-08-11 |
human |
| O Serri, H Beauregard, M Somma, R Comtois, N Jilwan, J Hard. Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia. Clinical and investigative medicine. Medecine clinique et experimentale. vol 11. issue 6. 1989-04-13. PMID:3229037. |
the results indicate the presence of a relative resistance to dopamine in patients with idiopathic hyperprolactinemia and in patients with microadenoma. |
1989-04-13 |
2023-08-11 |
human |